Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases
JTO Clin Res Rep
.
2020 Sep 12;2(1):100096.
doi: 10.1016/j.jtocrr.2020.100096.
eCollection 2021 Jan.
Authors
Jordi Remon
1
,
María Castro-Henriques
1
,
Laura Esteller
1
,
Josep Vives
2
Affiliations
1
Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, Spain.
2
Department of Radiology, Hospital HM Delfos, HM Hospitales, Barcelona, Spain.
PMID:
34589968
PMCID:
PMC8474250
DOI:
10.1016/j.jtocrr.2020.100096
No abstract available
Publication types
Case Reports